SCHEMBL6949567

SCHEMBL6949567

NC(CC(=O)N1CCC(Cc2cccs2)(C2CCCCC2)CC1)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 4/20 0.50
OPRD1 P41143 2/20 0.44
MC3R P41968 1/20 0.42
MC1R Q01726 1/20 0.42
DPP8 Q6V1X1 3/20 0.38
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
DPP7 Q9UHL4 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CACNA2D1 P54289 3/20 0.35
CACNA1B Q00975 3/20 0.35
CACNB1 Q02641 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6199494 0.83 MC4R (0.62) MC4RMC3RMC1RDPP8DPP7
SCHEMBL6476840 0.81 MC4R (0.60) MC4RMC3RMC1RDPP8DPP7
SCHEMBL6477249 0.77 MC4R (0.55) MC4RMC3RMC1RDPP8DPP7
SCHEMBL6180972 0.70 MC4R (0.43) MC4ROPRD1MC3RMC1RALDH1A1
SCHEMBL6476091 0.66 MC4R (0.70) MC4RMC3RMC1RDPP8DPP7
SCHEMBL6476088 0.66 MC4R (0.70) MC4RMC3RMC1RDPP8DPP7
SCHEMBL13735733 0.64 OPRM1 (0.47) MC4ROPRD1HTTCACNA2D1CACNA1B
SCHEMBL6476767 0.63 MC4R (0.60) MC4RMC3RMC1R
SCHEMBL6476771 0.63 MC4R (0.60) MC4RMC3RMC1R
Hydrochloric Acid SCHEMBL3403658 0.63 OPRM1 (0.46) MC4ROPRD1HTTCACNA2D1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040010010-A1 Melanocortin receptor ligands PROCTER & GAMBLE COMPANY, THE 2004-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040010010-A1 Melanocortin receptor ligands MC1R, MC4R, MC5R MC4R 2/4885OPRD1 28/4885MC3R 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.